Allegro Ophthalmics Company
Allegro Ophthalmics is dedicated to delivering and establishing Integrin Peptide TherapyTM.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
San Juan Capistrano, California, United States
Founded Date:
2011
Employees Number:
11-50
Funding Status:
Private Equity
Estimated Revenue:
Less than $1M
Register and Claim Ownership